Insiders Imugene Limited

Equities

Delayed Australian S.E. Other stock markets 02:10:46 2024-04-30 am EDT			5-day change	1st Jan Change
0.087 ^AUD	+6.10%		+2.35%	-20.91%

Apr. 16	Imugene Signs Deal to Sell Manufacturing Facility For $6 Million	MT
Apr. 16	Kincell Bio, LLC signed an asset purchase agreement to acquire North Carolina manufacturing facility from Imugene Limited for $6 million.	CI

Imugene Appoints Medical Chief	23-09-04	MT
Imugene Limited Appoints Paul Woodard as Chief Medical Officer	23-09-03	CI
Imugene Limited Appoints John Byon as Senior Vice President of Clinical Development	23-08-31	CI
Imugene Limited Appoints Dr Bradley Glover as Chief Operating Officer	23-08-20	CI
Imugene Appoints Dr Weitzman Interim Chief Medical Officer	23-07-18	CI
Australian shares rise on mining, tech boost; new RBA governor appointed	23-07-13	RE
Imugene Limited Announces Board Changes	23-06-20	CI
Imugene Announces Company Secretary Changes	23-03-01	CI
Imugene Names Chief Medical Officer; Shares Rise 3%	22-10-03	MT
Imugene Limited Appoints Giovanni Selvaggi as Chief Medical Officer	22-10-03	CI
Imugene Appoints Jakob Dupont as Non- Executive Director	22-09-06	CI
Imugene Appoints CFO	22-07-18	MT
Imugene Limited Appoints Mike Tonroe as Chief Financial Officer, Effective from September 2022	22-07-17	CI
Imugene Limited Announces Appointment of Dr. Sharon Yavrom as Executive Director, Clinical Scientist	22-06-30	CI
Imugene Limited Announces Board Changes	22-05-31	CI
Imugene Names Medical Chief; Shares Up 4%	22-01-31	MT
Imugene Limited Announces Appointment of Steven Cha as Chief Medical Officer and Member of the Executive Management Team	22-01-31	CI
Imugene's Chief Medical Officer to Retire; Shares Fall 4%	22-01-20	MT
Imugene Limited Announces Retirement of Rita Laeufle as Chief Medical Officer and the Board	22-01-20	CI
Imugene Limited Announces Management Changes	22-01-03	CI

No results for this search